UK's ECT Treatment Raises Concerns Over New Adverse Effects Found
A recent study published in the International Journal of Mental Health has sparked controversy over the use of electroconvulsive therapy (ECT), a treatment for depression that involves passing electricity through the brain to induce seizures. The research, which surveyed 747 ECT patients and 201 relatives and friends, has found that nearly two-thirds of participants experienced emotional blunting, while nearly a quarter reported heart problems such as arrhythmia.
The study's author, Professor John Read, is calling for ECT to be suspended pending further research into its safety and efficacy. He states that the existing evidence is "so flawed and inconclusive" that it would have no chance of gaining approval from regulatory bodies in the UK or US if introduced today.
ECT has been a topic of debate among mental health professionals, with some reporting improvements in symptoms but others citing long-term cognitive damage. Bipolar UK's director of research, Professor Tania Gergel, counters that there is "no evidence to substantiate claims" of major physical risks or permanent brain damage associated with modern ECT.
Despite the controversy, many experts acknowledge ECT's effectiveness in reducing severe depression symptoms and improving quality of life for patients. Clinical psychologist Lucy Johnstone highlights its importance as a treatment option, particularly for those who have tried other therapies without success. "Pills won't help," she notes, "so it quickly gets to the point where what do we try next? That's when ECT gets raised."
However, concerns remain about the lack of awareness surrounding ECT among patients and mental health professionals. A National Institute for Health and Care Excellence (NICE) spokesperson has emphasized the importance of informed consent and proper training for clinicians administering the treatment.
As the debate continues, one thing is clear: ECT remains a complex and multifaceted treatment that warrants further investigation into its benefits and risks.
A recent study published in the International Journal of Mental Health has sparked controversy over the use of electroconvulsive therapy (ECT), a treatment for depression that involves passing electricity through the brain to induce seizures. The research, which surveyed 747 ECT patients and 201 relatives and friends, has found that nearly two-thirds of participants experienced emotional blunting, while nearly a quarter reported heart problems such as arrhythmia.
The study's author, Professor John Read, is calling for ECT to be suspended pending further research into its safety and efficacy. He states that the existing evidence is "so flawed and inconclusive" that it would have no chance of gaining approval from regulatory bodies in the UK or US if introduced today.
ECT has been a topic of debate among mental health professionals, with some reporting improvements in symptoms but others citing long-term cognitive damage. Bipolar UK's director of research, Professor Tania Gergel, counters that there is "no evidence to substantiate claims" of major physical risks or permanent brain damage associated with modern ECT.
Despite the controversy, many experts acknowledge ECT's effectiveness in reducing severe depression symptoms and improving quality of life for patients. Clinical psychologist Lucy Johnstone highlights its importance as a treatment option, particularly for those who have tried other therapies without success. "Pills won't help," she notes, "so it quickly gets to the point where what do we try next? That's when ECT gets raised."
However, concerns remain about the lack of awareness surrounding ECT among patients and mental health professionals. A National Institute for Health and Care Excellence (NICE) spokesperson has emphasized the importance of informed consent and proper training for clinicians administering the treatment.
As the debate continues, one thing is clear: ECT remains a complex and multifaceted treatment that warrants further investigation into its benefits and risks.